Sean M. Healey & AMG Center for ALS
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and the Northeast ALS (NEALS) Consortium announced results from Regimen D of the HEALEY ALS Platform Trial evaluating pridopidine versus placebo in adults with amyotrophic lateral sclerosis (ALS).
Learn MoreA research group including several Healey Center investigators has a new report with promising results on the use of the experimental drug Toferson.
Clinical Leader highlights advances in ALS research, including the HEALEY ALS Platform Trial and BrainGate.
Join our quest to discover life-saving therapies for individuals who are affected by ALS. The key to our success is our dedication to collaboration. At the Sean M. Healey and AMG Center for ALS at Mass General, we partner with the best clinician-scientists, our patients and friends like you to turn laboratory successes into promising therapies.
